» Articles » PMID: 31430008

Diagnostic Performance of Multiparametric MRI in the Evaluation of Treatment Response in Glioma Patients at 3T

Overview
Date 2019 Aug 21
PMID 31430008
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MRI is one of the most important techniques to assess the treatment response of gliomas. However, differentiating tumor recurrence (TuR) from treatment effects (TrE) remains challenging.

Purpose: To compare the diagnostic performance of MR diffusion-weighted imaging (DWI), arterial spin labeling (ASL), proton MR spectroscopy (MRS), and amide proton transfer (APT) imaging in differentiating between TuR and TrE in posttreatment glioma patients.

Study Type: Prospective.

Population: Thirty patients with suspected tumor progression.

Field Strength/sequence: DWI, ASL, proton MRS, and APT imaging were performed at 3T MR.

Assessment: MR indices, including ADC, relative cerebral blood flow (rCBF), ratios of Cho/Cr, Cho/NAA, and NAA/Cr and APT-weighted (APTw) effect were obtained from DWI, ASL, proton MRS, and APT imaging, respectively. Indices were measured in the contralateral normal-appearing white matter and lesions defined on the Gd-enhanced T w image. TuR or TrE was either determined histologically or clinically from longitudinal MRI follow-up for at least 6 months.

Statistical Tests: The diagnostic performance of the indices was evaluated using Student's t-test, receiver operating characteristic (ROC) curve, and multivariate logistic regression analyses.

Results: Among the 30 patients, 16 were diagnosed as having TuR and the rest having TrE. The recurrent tumors showed a significantly higher APTw effect (1.56 ± 1.14%) and rCBF (1.44 ± 0.61) compared with lesions representing treatment effects (-0.44 ± 1.34% and 0.72 ± 0.25, respectively, with P < 0.001). The areas under the curve (AUCs) were 0.87 and 0.90 for APTw and rCBF, respectively, in differentiating between TuR and TrE. Combining APTw and rCBF achieved a higher AUC of 0.93. MRS index ratios of Cho/Cr (P = 0.25), Cho/NAA (P = 0.16), and NAA/Cr (P = 0.86) and ADC (P = 0.37) showed no significant differences between TuR and TrE lesions, with AUCs lower than 0.70.

Data Conclusion: Compared with DWI and MRS, ASL and APT imaging techniques showed better diagnostic capability in distinguishing TuR from TrE.

Level Of Evidence: 1 Technical Efficacy: Stage 4 J. Magn. Reson. Imaging 2020;51:1154-1161.

Citing Articles

Radiomic feature reliability of amide proton transfer-weighted MR images acquired with compressed sensing at 3T.

Wu J, Huang Q, Shen Y, Guo P, Zhou J, Jiang S Int J Imaging Syst Technol. 2024; 34(2).

PMID: 39185083 PMC: 11343505. DOI: 10.1002/ima.23027.


Advances in diffuse glioma assessment: preoperative and postoperative applications of chemical exchange saturation transfer.

Deng H, Zhang H, Huang B, Deng J, Luo S, Li W Front Neurosci. 2024; 18:1424316.

PMID: 39148521 PMC: 11325484. DOI: 10.3389/fnins.2024.1424316.


Performance of amide proton transfer imaging to differentiate true progression from therapy-related changes in gliomas and metastases.

Essed R, Prysiazhniuk Y, Wamelink I, Azizova A, Keil V Eur Radiol. 2024; 35(2):580-591.

PMID: 39134744 PMC: 11782315. DOI: 10.1007/s00330-024-11004-y.


Amide proton transfer-weighted and arterial spin labeling imaging may improve differentiation between high-grade glioma recurrence and radiation-induced brain injury.

Chen L, Huang L, Zhang J, Li S, Li Y, Tang L Heliyon. 2024; 10(11):e32699.

PMID: 38961946 PMC: 11219995. DOI: 10.1016/j.heliyon.2024.e32699.


Velocity-Selective Arterial Spin Labeling Perfusion in Monitoring High Grade Gliomas Following Therapy: Clinical Feasibility at 1.5T and Comparison with Dynamic Susceptibility Contrast Perfusion.

Lambrecht S, Liu D, Dzaye O, Kamson D, Reis J, Liebig T Brain Sci. 2024; 14(2).

PMID: 38391701 PMC: 10886779. DOI: 10.3390/brainsci14020126.